Anavex Life Sciences (AVXL) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

AVXL Anavex Life Sciences

Watchlist

8.690
-0.520-5.65%

Close Dec 18 16:00 ET

736.87MMarket Cap-17.04P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Earnings Preview: AVXL to Report Financial Results Pre-market on December 23
Moomoo NewsDec 17 20:00 ET
Anavex Life Sciences Corp. to Announce Fiscal Year 2024 Financial Results on December 23, 2024
Quiver QuantitativeDec 16 07:41 ET
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer's Disease Data at J.P. Morgan 2025 Healthcare Conference
GlobeNewswireDec 9 07:30 ET
Earnings Week Ahead: ORCL, GME, ADBE, COST, AVGO, M and More
Seeking AlphaDec 8 08:01 ET
Anavex Life Sciences Down Over 13%, On Track for Largest Percent Decrease Since January -- Data Talk
Dow JonesDec 5 15:12 ET
Anavex Life Sciences to Present at the 7th Annual Evercore ISI HealthCONx Conference 2024
GlobeNewswireDec 2 07:30 ET

Comments

$Anavex Life Sciences (AVXL.US)$ crossing over mid Bollinger band on day chart , possible to see 9. + soon

$Anavex Life Sciences (AVXL.US)$
$Sunshine Biopharma (SBFM.US)$
$Rumble (RUM.US)$
Got a few superbouncy balls this evening.
making me dizzy 🤣

$Anavex Life Sciences (AVXL.US)$ 👀

$Anavex Life Sciences (AVXL.US)$
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
Anavex Life Sciences (Nasdaq: AVXL) announced it will present new long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial for blarcamesine in early Alzheimer's disease at the J.P. Morgan 2025 Healthcare Conference. The presentation will showcase data from up to 144 weeks of continuous treatm...

$Anavex Life Sciences (AVXL.US)$ nice

Read more

US

Overall

No Data